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Objectives To determine the excess risk of non-chromosomal
congenital anomaly (NCA) among teenage mothers and older
mothers.
Design and setting Population-based prevalence study using data
from EUROCAT congenital anomaly registers in 23 regions of
Europe in 15 countries, covering a total of 1.75 million births
from 2000 to 2004.
Participants A total of 38 958 cases of NCA that were live births,
fetal deaths with gestational age ‡20 weeks or terminations of
pregnancy following prenatal diagnosis of a congenital anomaly.
Main outcome measures Prevalence of NCA according to
maternal age, and relative risk (RR) of NCA and 84 standard
NCA subgroups compared with mothers aged 25–29.
Results The crude prevalence of all NCA was 26.5 per 1000 births
in teenage mothers (<20 years), 23.8 for mothers 20–24 years,
22.5 for mothers 25–29 years, 21.5 for mothers 30–34 years, 21.4
for mothers 35–39 years and 22.6 for mothers 40–44 years. The
RR adjusted for country for teenage mothers was 1.11 (95% CI
1.06–1.17); 0.99 (95% CI 0.96–1.02) for mothers 35–39; and 1.01
(95% CI 0.95–1.07) for mothers 40–44. The pattern of maternal
age-related risk varied significantly between countries: France,
Ireland and Portugal had higher RR for teenage mothers,
Germany and Poland had higher RR for older mothers. The
maternal age-specific RR varied for different NCAs. Teenage
mothers were at a significantly greater risk (P < 0.01) of
gastroschisis, maternal infection syndromes, tricuspid atresia,
anencephalus, nervous system and digestive system anomalies
while older mothers were at a significantly greater risk (P < 0.01)
of fetal alcohol syndrome, encephalocele, oesophageal atresia and
thanatophoric dwarfism.
Conclusions Clinical and public health interventions are needed to
reduce environmental risk factors for NCA, giving special
attention to young mothers among whom some risk factors are
more prevalent. Reassurance can be given to older mothers that
their age in itself does not confer extra risk for NCA.
Keywords Maternal age, non-chromosomal anomalies, older
mothers, prevalence, relative risk, teenage mothers.
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Introduction
It is well known that older mothers have a higher risk of
chromosomal anomalies such as Down syndrome,1,2 but
whether they are at excess risk of non-chromosomal con-
genital anomalies (NCA) is less clear. At the other end of
the maternal age spectrum, teenage mothers have a low
risk of chromosomal trisomy, but a higher risk of some
NCA,3 in particular the abdominal wall defect gastroschi-
sis.4–6 Maternal age may be an indicator of intrinsic bio-
logic factors and previous reproductive history (including
parity) or extrinsic factors, such as education, nutritional
status or social and behavioural influences. If maternal
age risks are related to extrinsic factors rather than intrin-
sic biological factors, they can be expected to vary both
geographically and in time. Risk may be associated with
current or past exposures. Cohorts of mothers may differ
in risk according to the year they were born rather than
their age at delivery. Advanced maternal age may also be
associated with a differentially increased risk of miscarry-
ing an affected fetus.
In the last two decades, the maternal age profile of the
population has changed markedly in Europe, with average
maternal age rising each year. It is important to have
accurate information on maternal age-specific risks of
NCA to gauge the implications of this rise in maternal* Members of the EUROCAT Working Group are listed in Appendix.
ª 2009 The Authors Journal compilation ª RCOG 2009 BJOG An International Journal of Obstetrics and Gynaecology 1111
DOI: 10.1111/j.1471-0528.2009.02227.x
www.bjog.org
Epidemiology
age for public health, for clinical care needs and for pro-
viding information to women of childbearing age. Some
of the older literature on maternal age risks is difficult to
interpret, since it is likely that chromosomal anomalies in
babies with structural malformations were underdiag-
nosed, thus creating artefactually increased risks for older
mothers of apparently non-chromosomal anomalies.7
Many studies have been too small to consider mothers
over 40 specifically, or to provide precise estimates for
specific types of NCA.
The persistent high rate of teenage pregnancy in some
European populations is of continuing concern,8,9 espe-
cially its relationship with deprivation and unplanned preg-
nancy.10,11 This group experiences poorer pregnancy
outcomes overall12,13 due both to their unfavourable envi-
ronment and biologic immaturity.14 There is little informa-
tion from Europe on the overall risk of NCA in teenage
mothers.
EUROCAT is a network of population-based congenital
anomaly registers covering nearly one-third of births in
Europe, with a standardised methodology. In this paper,
we analyse the EUROCAT database to determine maternal
age-specific risks of NCA.
Method
The EUROCAT database consists of all cases of congenital
malformations notified by regional or national registries
including live born cases, cases resulting in fetal deaths
from 20 weeks gestation and cases that were subsequently
terminated following prenatal diagnosis of a congenital
malformation. Twenty-three regional registries in 15 Euro-
pean countries participated in the study, all of which could
provide maternal age data for both cases and population,
for the period 2000–2004. Information on each of the reg-
istries and their methods of case ascertainment can be
found on the EUROCAT website.15 Maternal age was
defined as age at delivery of baby and was known for 97%
of NCA cases. The remaining 3% of cases with unknown
maternal age were excluded.
Congenital anomaly cases are coded within the range
740–759 in ICD9 or the Q chapter in ICD10 code (Inter-
national Classification of Disease). One case can have up
to nine malformation or syndrome codes. The EUROCAT
Data Management Program (EDMP) automatically assigns
all congenital anomaly codes to one of 84 EUROCAT
NCA subgroups (see ‘EUROCAT Guide 1.3: Instructions
for the registration and surveillance of congenital anoma-
lies’ for the list of subgroups and codes).16 A case can be
counted only once in each subgroup but may be counted
within more than one subgroup. All cases with a diagno-
sis coded within ICD9/BPA 758.00–758.99 and ICD10
Q90.0–Q99.9, excluding microdeletions and balanced
translocations, are classified as chromosomal anomalies
and excluded from this study. For comparative purposes
only, a dataset of these chromosomal cases was extracted
for the same registries and time period in order to calcu-
late the maternal age-specific prevalence of chromosomal
cases.
The number of births (live and still) by maternal age
group was supplied by the participating registries, obtained
from appropriate statistical agencies or hospitals within the
areas. Maternal age was known for 97% of births in the
study population. The remaining 3% were assumed to fol-
low the same maternal age distribution as those of known
maternal age, within each registry and year.
Statistical analysis
Maternal age was categorised into 7 age-bands (<20, 20–24,
25–29, 30–34, 35–39, 40–44 and 45+ years) and prevalence
rates per 1000 births were calculated within each maternal
age group as:
number of cases among livebirthsþ fetal deaths
ð20 weeks gestationÞþ terminations of pregnancies
(TOPFA) following prenatal diagnosis of malformation=
total number of livebirths and stillbirths in the population
:
A Poisson regression model using STATA version 9.0
(StataCorp LP, College Station, TX, USA) was used to
derive maternal age-specific relative risks (RR) relative to
the 25- to 29-year age group baseline. This baseline group
was chosen as it is in the middle of the age range (one
age category removed from ages <20 and over 35) and is
commonly used as a standard baseline in the literature. A
model for all NCA first adjusting for country was fitted.
Adjustment for country was designed to adjust for the
possibility that countries with high proportions of moth-
ers in any one age group also had generally high NCA
prevalence, and that this would bias the RR estimates
between age groups. A second model, after excluding
mothers 45+, allowed for interaction between country and
maternal age using the UK as an arbitrary baseline coun-
try. We give country-specific results by multiplying the
UK RR by the country-specific RR for each maternal age
group. A third model for each of the 84 NCA subgroups
adjusting for country was fitted, which did not allow for
interactions due to the lack of statistical power. Because
of the large number of subgroups and the problem of
spuriously statistically significant results by multiple test-
ing, only NCA subgroups with significantly increased risk
at P < 0.01 level are presented in the Results. Full results
for all 84 subgroups are available online in the Appendix
(S1). Risk estimates for the mothers 45+ years are not
shown where small numbers led to very large standard
Loane et al.
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errors (Appendix S1). Maternal age was modelled as a
categorical variable in order to investigate maternal age
risk curves of any shape.
Results
Maternal age population distribution
Overall in 2000–2004, 4% of mothers in the population
were aged <20 years, 14% were aged 20–24 years, 28% were
aged 25–29 years, 34% were aged 30–34 years, 17% were
aged 35–39 years, 3% were 40–44 years and 0.14% were aged
45 years and older. These proportions are generally consis-
tent with the European Union maternal age distribution
based on EUROSTAT figures for livebirths in the same coun-
tries and time period.17
Table 1 shows the geographical variation in the propor-
tion of younger (<20 years) and older mothers (40+ years)
between countries, 2000–2004. The proportion of teenage
mothers ranged from <2% in France, Italy, the Nether-
lands, Spain and Switzerland to 9% in the UK. The
proportion of mothers 35 years and over ranged from 9%
in Poland to 25%–28% in France, Italy and Spain. The
proportion of mothers 40 years and over ranged from <2%
in Belgium, Croatia, Denmark, Germany and Poland to 6%
in France.
Maternal age prevalence and risk
Between 2000 and 2004, there were 38 958 cases of NCA
reported among 1.74 million births (including 61 cases
born to mothers aged 45+ years), giving a total prevalence
of 22.4 per 1000 births. Livebirths accounted for 88.8% of
all NCA, stillbirths 1.5% and termination of pregnancy
(TOPFA) 9.7% of all NCA. Mothers aged 45 years and
older had the highest proportion of stillbirths (3%) while
mothers aged 35–39 and 40–44 years had the highest pro-
portion of TOPFAs (11% each). The crude prevalence of
all NCAs according to maternal age is shown in Figure 1.
Teenage mothers had the highest prevalence of all NCA
(26.5 per 1000 births). Prevalence decreased as maternal
age increased (23.8 per 1000 births for mothers
20–24 years, 22.5 per 1000 births for mothers 25–29 years,
21.5 for mothers 30–34 years, 21.4 for mothers
Table 1. Total births and the proportion of births according to maternal age for each country from 2000 to 2004
Total births Maternal age in years (%)
<20 20–34 35–39 40–44 45+
Austria 52194 4 82 12 2 0.07
Belgium 89189 2 85 11 2 0.09
Croatia 27998 6 83 9 2 0.08
Denmark 26745 2 83 13 2 0.05
France 245903 1 74 20 5 0.29
Germany 104574 7 81 10 2 0.07
Ireland 164629 5 72 19 3 0.11
Italy 276955 1 73 21 4 0.14
Malta 19803 6 82 9 2 0.08
The Netherlands 100552 1 79 17 2 0.09
Poland 170725 6 85 7 2 0.09
Portugal 56648 7 80 11 2 0.18
Spain 179907 2 70 24 4 0.16
Switzerland 35652 1 78 18 3 0.10
UK 189244 9 75 13 3 0.12
Total 1740718 4 77 16 3 0.14
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Figure 1. Prevalence of non-chromosomal anomalies and
chromosomal anomalies according to maternal age, 2000–2004.
Maternal age and non-chromosomal anomalies
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35–39 years), until a slight increase in mothers 40–44 years
(22.6 per 1000 births) and a further increase in mothers
45+ years (25.3 per 1000 births). The prevalence of all
chromosomal anomalies is shown for comparison—for
mothers 40–44, the risk of chromosomal and NCA are sim-
ilar. Chromosomal anomalies surpass NCAs in risk for
mothers 45 and over.
Table 2 shows the RR of all NCAs according to maternal
age compared with mothers aged 25–29 for all countries
combined and for all individual countries. The RR for
teenage mothers (compared with mothers aged 25–29) of
NCA, adjusted for country, was 1.11; 95% CI 1.06–1.17.
Mothers between 25 and 44 years had the lowest risk of
NCA. Mothers 45+ had the same RR as teenage mothers,
but it was not statistically significant in this age group
(RR = 1.11, 95% CI 0.87–1.43, data not shown).
A model including interaction between maternal age and
country was found to provide a significantly better fit
(P < 0.001). In the UK (baseline country), the risk of NCA
was 1.09 in teenage mothers, 0.96 in mothers 35–39 and
1.06 in mothers 40–44 years (Table 2). Teenage mothers in
France, Ireland and Portugal had a significantly greater RR
of NCAs (relative to mothers aged 25–29) than teenage
mothers in the UK. Mothers 35–39 years in Austria,
Germany and Poland and mothers 40–44 years in Germany
had significantly greater RR of NCA compared with the RR
of their UK counterparts (Table 2). Mothers 35–39 and
40–44 years in France and the Netherlands had significantly
lower RR of NCA compared with older mothers in UK.
Table 3 shows the specific NCAs for which teenage
mothers had significantly increased risk (P < 0.01) com-
pared with mothers aged 25–29. Teenage mothers were six
times more likely to have a baby with gastroschisis (RR
6.32, 95% CI 4.75–8.41) and almost five times more likely
to have malformations resulting from three maternal infec-
tions [congenital rubella, congenital cytomegalovirus
(CMV) and congenital toxoplasmosis] during the first
trimester of pregnancy (RR 4.57, 95% CI 2.24–9.32) com-
pared with 25- to 29-year-old mothers. Teenage mothers
had a nearly three-fold greater risk of having a baby with
tricuspid atresia and stenosis (RR = 2.63, 95% CI
1.37–5.06) compared with baseline mothers. Teenage
mothers were also at greater risk of having a baby with
anencephalus (RR = 1.74, 95% CI 1.22–2.47), nervous
system anomalies (RR 1.39, 95% CI 1.20–1.61), digestive
system anomalies (RR = 1.31, 95% CI 1.09–1.57) and
abdominal wall defects (RR 3.52 95% CI 2.80–4.44).
Table 3 shows the specific NCAs for which older moth-
ers, either 35–39 years or 40–44 years, had significantly
increased risk compared with mothers aged 25–29. Older
mothers were 7–12 times more likely to have babies with
fetal alcohol syndrome (mothers 35–39 years: RR 7.13;
95% CI 2.31–22.03; mothers 40–44 years: RR 11.66; 95%
CI 2.89–47.07). Mothers 35–39 years were at greater risk
of having a baby with thanatophoric dwarfism (RR 2.59;
95% CI 1.32–5.08), but no increased risk was found in
mothers 40–44 years compared with baseline mothers. An
increased risk of encephalocele was found in babies born
to mothers over 40 (RR 2.36; 95% CI 1.25–4.48), but not
in mothers 35–39 years, compared with baseline mothers.
A similar age-specific RR was found in the offspring of
mothers over 40 for oesophageal atresia (RR 2.10; 95% CI
1.32–3.35), but not in mothers 35–39 compared with the
baseline.
A ‘U-shaped’ distribution curve with younger and older
mothers showing significantly increased risk was reported
for respiratory anomalies (P < 0.001) (Appendix S1). Teen-
age mothers had a 50% increased risk of having babies with
respiratory anomalies while mothers over 40 years had a
43% increased risk compared with 25- to 29-year-old
mothers (Appendix S1).
The Appendix lists the RR for all NCA subgroups
according to maternal age compared with women aged
25–29, together with the statistical significance of any
maternal age effect. As a large numbers of comparisons are
being made there will be spurious statistically significant
results and therefore care must be taken in interpreting
individual statistically significant results.
Discussion
Overall in Europe, we find that teenage mothers are at
higher risk of NCA, but older mothers 35–44 years are not.
However, the maternal age pattern of risk differs between
countries, suggesting that it is not biological age that is
associated with risk of NCA, but reproductive (including
parity and use of Assisted Reproductive Technology),
social, ethnic, exposure or lifestyle factors that have a
different relationship with maternal age in different
European countries. We should therefore expect apparently
conflicting results between published studies of different
populations, as has indeed been found in the past. This
finding is in contrast to the older maternal age-related risks
for chromosomal anomalies such as Down’s syndrome,
which are the same across different countries, indicative of
intrinsic biological risk factors.18,19
The sharp increase in average maternal age has led to
public health concerns over worsening pregnancy out-
comes.20 Our results show that older maternal age is a neg-
ligible risk factor for NCAs, especially when compared to
chromosomal anomalies. Since the rise in maternal age in
Europe is especially associated with women of higher social
status, it may have resulted in decreasing NCA risks in this
age group compared to past decades.21 Nevertheless, in
some countries, particularly Germany and Poland, older
maternal age seems to be a more important risk factor.
Loane et al.
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This may be associated with risk factors more prevalent
among these mothers either during the years of the study
(2000–2004) or in their earlier lives.
Compared with the middle of the age range (25–29 years),
teenage mothers had an 11% excess risk (95%CI 6-17%). This
finding is consistent with findings from North America,3,22,23
but some countries (particularly France, Ireland and Portu-
gal) had higher risks than others. Teenage mothers had
a five times increased risk (and mothers 20–24 years had
double the risk) of maternal infection syndromes compared
with mothers aged 25–29 years. Congenital CMV infection
accounted for all but two of the 13 maternal infection cases
in teenage mothers in our study. Maternal age <25 years
and recent onset of sexual activity are known risk factors
for CMV.24 In addition, hydrocephaly, microcephaly and
gastroschisis have been associated with maternal infec-
tions,25,26 and it is possible that higher risks for these mal-
formations among teenage mothers are mediated in part by
undiagnosed infection.
The high risk of the abdominal wall defect gastroschisis in
young mothers is well known.4–6 Although social depriva-
tion, substance abuse, smoking and low body mass index
have been indicated by aetiologic studies as risk factors for
gastroschisis, a complete explanation of the young maternal
age risk has not been found. It may be that these mothers are
in addition more biologically vulnerable to these risk factors.
Vascular disruption has been proposed as a pathogenic
mechanism underlying the risk of certain types of NCA,
including gastroschisis, in young mothers,27–29 but not all
anomalies that have been associated with vascular disruption
showed higher risks in teenage mothers in this study.
The high risk of anencephalus, in teenage mothers has
previously been reported3 and may relate to lower folic
acid status because of poorer nutrition or lower pericon-
ceptional folic acid supplementation rates associated with
unplanned pregnancies and lower socioeconomic status.30
However, the lack of risk in teenage mothers for spina
bifida suggests other factors are also important.
Mothers who survived congenital heart defects as infants
are now giving birth (although some high risk mothers are
advised not to get pregnant), and may be at greater risk of
having children with the same or different anomalies.31,32 In
this regard, the surveillance of prevalence of babies with con-
genital heart disease among younger mothers is of interest.
The finding regarding risks of tricuspid atresia among teen-
age mothers needs confirmation in further studies, as the risk
estimate is based on a small number of cases, but is unlikely
to be explained by such a survival effect.
Despite the lack of overall increased risk in older moth-
ers, there were some specific congenital anomaly subgroups
which did show a significantly increased risk worthy of
comment. Our finding that fetal alcohol syndrome is
strongly associated with older maternal age needs further
follow up. Fetal alcohol syndrome is underascertained by
Table 3. Adjusted relative risk* for congenital anomalies with significantly greater risk in mothers <20 years, and in mothers 35–39 years
or 40–44 years compared with mothers aged 25–29, EUROCAT registries from 15 countries combined, 2000–2004
NCA n RR 95% CI
Mothers <20 years
Nervous system 215 1.39 (1.20–1.61)
Anencephalus and similar 40 1.74 (1.22–2.47)
Tricuspid atresia and stenosis 12 2.63 (1.37–5.06)
Digestive system 136 1.31 (1.09–1.57)
Abdominal wall defects 113 3.52 (2.80–4.44)
Gastroschisis 98 6.32 (4.75–8.41)
Maternal infection syndromes** 13 4.57 (2.24–9.32)
Mothers 35–39, 40–44 years
Encephalocele 35–39 35 1.39 (0.89–2.17)
Encephalocele 40–44 12 2.36 (1.25–4.48)
Oesophageal atresia 35–39 69 1.28 (0.93–1.75)
Oesophageal atresia 40–44 22 2.10 (1.32–3.35)
Thanatophoric dwarfism 35–39 21 2.59 (1.32–5.08)
Thanatophoric dwarfism 40–44 1 0.62 (0.08–4.75)
Fetal alcohol syndrome 35–39 13 7.13 (2.31–22.03)
Fetal alcohol syndrome 40–44 4 11.66 (2.89–47.07)
*Adjusted for country.
**Diagnosed syndromes involving major malformations.
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most congenital anomaly registers as it is often diagnosed
after the first year of life and usually does not involve
major structural malformations. Our finding, although
based on small numbers, could indicate that older mothers
are more vulnerable to alcohol effects with respect to
malformation risk, or that they are more frequently heavy
alcohol consumers periconceptionally, or that their chronic
consumption results in different risks from teenage binge
drinking, or that they are more likely to be known to
clinicians as heavy alcohol consumers.
Thanatophoric dwarfism is associated with new muta-
tions known to be related to older paternal age.33 It is
therefore not surprising that we find an effect of older
maternal age (35–39 years). There was little statistical
power to investigate the over 40-year age group.
Our finding of an increased risk for oesophageal atresia
(with or without fistula) among older mothers is consistent
with the findings of a Swedish case–control study 1982–
2004,34 but is contrary to an earlier European study which
found an increased risk for younger mothers <20 years in
1980–88.35 This could be indicative of a cohort effect as
the older mothers in this study and the younger mothers
in the earlier European study were born in the 1960s. The
increased risk of encephalocele among older mothers seems
also to be counter to previous findings.3,36 It must be
borne in mind, that inconsistent findings in the literature
may be due to chance differences as a result of multiple
testing in this and other studies.
The strengths of this study are the large size of the study
population combined with high case ascertainment,
standardised methodology and specific diagnostic informa-
tion. However, even in such a large study, there is not
sufficient statistical power to examine whether maternal
age-specific RR for specific congenital anomaly subgroups
vary between countries because of their individual rarity.
We would have liked to analyse information in the data-
base on parity—among NCA cases, 80% of teenage
mothers were primiparous compared with 55% of mothers
20–24, 46% of mothers 25–29, 34% of mothers 30–34,
23% of mothers 35–39 and 18% of mothers 40+ years.
However, there is no comparable population information
on parity for most of the populations included. This high-
lights the importance of developing general perinatal
information for Europe.37
A number of artefacts can lead to small apparent age-
related risk increases. Mismatches between numerator and
denominator can bias estimates of risk. For example, we
did not correct TOPFA for age at expected delivery, which
means that mothers aged 19 that had a TOPFA, may well
have been in the 20–24 age group if they had gone to term.
This would lead to there being slightly more cases of con-
genital anomaly in mothers <20 years compared with the
corresponding birth population. However, since only 7% of
teenage mothers had terminations of pregnancy, and of
those 61% were under 19 years, this would not explain
excess risk in this age group. For mothers 40–44, lack of
age correction of terminations would have underestimated
the age-related risk slightly.
Since we only include spontaneous fetal deaths from
20 weeks gestation, it is of course possible that different
maternal age effects would be found if all incident cases
during pregnancy could be considered, because of differen-
tial in utero survival effects. Older mothers have an
increased risk of stillbirth and early miscarriage38,39 and it
is possible that this applies particularly to more vulnerable
malformed fetuses. The increased risk of multiple births to
mothers 35–39 years and the increased risk of congenital
anomalies among multiple births (5% of our NCA cases
were multiple births) also need further investigation in
relation to older maternal age risks.
Clinical and public health interventions are needed to
reduce environmental risk factors for NCA, giving special
attention to young mothers among whom some risk factors
are more prevalent. Reassurance can be given to older
mothers that their age in itself does not confer extra risk
for NCA.
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